- Home
- ADMA vs PAGP Comparison
ADMA vs PAGP Comparison
Compare ADMA & PAGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ADMA | PAGP |
|---|---|---|
| Founded | 2004 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Natural Gas Distribution |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.5B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | ADMA | PAGP |
|---|---|---|
| Price | $20.16 | $18.97 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 8 |
| Target Price | ★ $28.50 | $20.14 |
| AVG Volume (30 Days) | ★ 3.7M | 1.2M |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 8.02% |
| EPS Growth | ★ 205.35 | 11.94 |
| EPS | 0.86 | ★ 0.95 |
| Revenue | $488,559,000.00 | ★ $46,917,000,000.00 |
| Revenue This Year | $21.08 | N/A |
| Revenue Next Year | $25.98 | $6.70 |
| P/E Ratio | $23.56 | ★ $20.03 |
| Revenue Growth | ★ 27.63 | N/A |
| 52 Week Low | $13.50 | $16.61 |
| 52 Week High | $25.67 | $22.31 |
Technical Indicators
Market Signals| Indicator | ADMA | PAGP |
|---|---|---|
| Relative Strength Index (RSI) | 76.50 | 72.50 |
| Support Level | $18.73 | $17.62 |
| Resistance Level | $19.48 | $18.69 |
| Average True Range (ATR) | 0.74 | 0.29 |
| MACD | 0.33 | 0.12 |
| Stochastic Oscillator | 98.00 | 95.91 |
Price Performance
Historical ComparisonAbout ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
About PAGP Plains GP Holdings L.P. Units representing Limited Partner Interests
Plains GP Holdings LP provides transportation, storage, processing, fractionation, and marketing services for crude oil, refined products, natural gas liquids, liquefied petroleum gas, and related products. The group manages its operations through two operating segments: Crude Oil and NGL.